1. Home
  2. ITP vs ERNA Comparison

ITP vs ERNA Comparison

Compare ITP & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

N/A

Current Price

$0.12

Market Cap

2.4M

ML Signal

N/A

Logo Eterna Therapeutics Inc.

ERNA

Eterna Therapeutics Inc.

N/A

Current Price

$1.97

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITP
ERNA
Founded
1996
2018
Country
China
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ITP
ERNA
Price
$0.12
$1.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 154.9K
25.8K
Earning Date
11-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
1.01
★ 31.29
EPS
★ N/A
N/A
Revenue
★ $75,837,943.00
$582,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.12
$1.84
52 Week High
$0.33
$47.25

Technical Indicators

Market Signals
Indicator
ITP
ERNA
Relative Strength Index (RSI) 37.28 31.81
Support Level $0.12 $1.84
Resistance Level $0.20 $2.26
Average True Range (ATR) 0.01 0.17
MACD -0.00 0.06
Stochastic Oscillator 32.16 24.05

Price Performance

Historical Comparison
ITP
ERNA

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.

Share on Social Networks: